CIK 0000926617 · Non-accelerated filer<br>Smaller reporting company
Aspira Women's Health Inc.
Sign in to watch- Ticker
- AWHL
- Exchange
- OTC
- Industry
- In Vitro & In Vivo Diagnostic Substances
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 330595156
- Phone
- 512-519-0400
- Business address
- 12117 BEE CAVES ROAD BUILDING THREE, SUITE 100, AUSTIN, TX, 78738
- Former names
- VERMILLION, INC., CIPHERGEN BIOSYSTEMS INC
- 424B3 Offering Prospectus
- CORRESP Other Correspondence Between Filers and SEC Staff
- S-1/A Offering Registration Statement
- CORRESP Other Correspondence Between Filers and SEC Staff
- S-1/A Offering Registration Statement
- CORRESP Other Correspondence Between Filers and SEC Staff
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- UPLOAD Other SEC-generated Letter
- DEFR14A Other DEFR14A
- 8-K Event Delisting notice
- S-1 Offering Registration Statement
- ARS Other Annual Report to Security Holders
- DEF 14A Proxy Proxy Statement
- 8-K Event Material agreement · Unregistered share sale · Executive or director change · Other events
- 4 Option exercise Director acquired 5,313 shares (option exercise)
- 4 Option exercise Director acquired 5,156 shares (option exercise)
- 4 Option exercise Director acquired 1,615 shares (option exercise)
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
Page 5 of 78 · 1,549 filings